Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003950
What this trial is testing

Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 16
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Not applicableUnknownNCT03846882
What this trial is testing

FDG - PET / MRI in Patients With Rectal Cancer

Who this might be right for
Rectal CancerLymph Node Metastases
Region Västerbotten 100
Early research (Phase 1)UnknownNCT03129139
What this trial is testing

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+7 more
Minneamrita Therapeutics LLC 66
Large-scale testing (Phase 3)Study completedNCT00002570
What this trial is testing

Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease

Who this might be right for
Colorectal Cancer
NCIC Clinical Trials Group 67
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00640471
What this trial is testing

Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NCIC Clinical Trials Group 750
Large-scale testing (Phase 3)UnknownNCT05074966
What this trial is testing

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

Who this might be right for
Colo-rectal Cancer
Chinese Academy of Medical Sciences 314
Not applicableStudy completedNCT05398822
What this trial is testing

The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer

Who this might be right for
Rectal Cancer
East Suffolk and North Essex NHS Foundation Trust 113
Testing effectiveness (Phase 2)UnknownNCT03225937
What this trial is testing

Evaluation of Trastuzumab in Combination With Lapatinib or Pertuzumab in Combination With Trastuzumab-Emtansine to Treat Patients With HER2-positive Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 54
Not applicableStudy completedNCT00564694
What this trial is testing

Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 350
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Early research (Phase 1)Study completedNCT03317119
What this trial is testing

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colon CarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Carcinoma+22 more
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT00316914
What this trial is testing

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Colorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Ended earlyNCT00004193
What this trial is testing

ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07815834
What this trial is testing

FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)

Who this might be right for
Colon Rectal Cancer AdenocarcinomaPeritoneal (Metastatic) CancerSecond-line Treatment+2 more
Fudan University 198
Testing effectiveness (Phase 2)Study completedNCT02305758
What this trial is testing

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Untreated Metastatic Colorectal Cancer
AbbVie 130
Next Page